Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency in drug candidates. Commonly employed in research settings for optimizing lead compounds in oncology and inflammatory disease programs. Also utilized in medicinal chemistry for scaffold modification to improve metabolic stability and bioavailability.